BIG NEWS! We have launched our newest campaign: the #PIeChallenge. The #PIechallenge is a social media awareness/fundraising campaign for PI (primary immunodeficiency).
What is it? The way we’re asking you to spread awareness and fundraise is to bake a homemade pie, post a photo of the pie on social media with our attached copy/paste message, and then tag at least 3 friends that you think have a knack for baking or a love for a good cause to take on the challenge. We encourage you to get as creative with your pies as possible. They can be decorative, they can be weird, they can be enormous/tiny, they can be apple pies, pumpkin pies, or pizza pies. The choice is yours! Have fun with it.
Lastly, we are asking for a donation of $5.00 once you have posted your photo. 100% of your donation will go to the cause.
Six children’s hospitals need $6,000 per year to help children and their families in financial crisis. That only helps 12 families with a $500 grant each. Diagnosis and treatment of infants with Primary Immunodeficiency can take several months, requiring one parent to leave work and throwing the family into financial crisis. Additional costs for medications, medical equipment, travel, accommodation, parking, meals creates a strain when the families energy should be on their child getting better. Help a child nearby. Your donation will be allocated to the nearest hospital to your postal code.
Immunodeficiency Canada has participated in the Scotiabank Charity Challenge since 2012 and has raised funds that had helped families living with PI. The Scotiabank Charity Challenge is a special event for the organization because it brings together staff, patients, families and healthcare professionals for one day as they walk/run together to raise money.
Thanks to Immunodeficiency Canada’s generous corporate sponsorship covering our administration cost, 100% of your donation will go to help families and individuals living with PI. This year, 2016, over $11,000 was raised going directly to programs and services.
LymphoSign Journal publishes novel clinical, translational, or basic research articles aimed at clinicians and scientists in the fields of immunology, gastroenterology, neurology, dermatology, infectious diseases, rheumatology, and hematology. The focus is on defining the molecular basis and treatment of various immune disorders like innate or adaptive immunodeficiency, bone marrow failure, autoimmunity and auto inflammatory disorders and lymphoid malignancies. The Journal also publishes papers that can directly and immediately improve diagnosis and management of patients, including practice guidelines and algorithms.
Business Analyst-Business Planning-Customer Services,
Bombardier Commercial Aircraft @Bombardier
“Within a week of Bombardier’s Jeans Day Team distributing the 10 Warning Signs, we received a phone call from a patient needing help,” says Richard Thompson, CEO of Immunodeficiency Canada. Read More »
Implementation of newborn screening for SCID (Severe Combined Immunodeficiency), a major accomplishment for Immunodeficiency Canada.
“This is a monumental triumph to children born with severe combined immunodeficiency (SCID) and their families. Newborn screening will detect this problem early before complications develop, and allow for prompt life-saving interventions such as bone marrow transplantation. Read More »